ICU Beds To Be Increased & Plasma Therapy to Continue in Delhi

The statement comes after a study by ICMR found that the use of plasma therapy does not help to reduce deaths.

1 min read
Image for representation.

Amid the rapid increase in Covid-19 cases in Delhi, Chief Minister Arvind Kejriwal on Thursday, 10 September directed all the authorities to increase the number of ICU beds, Delhi Health Minister Satyendar Jain briefed the media.

He also stated that plasma therapy will continue to be used in the national capital, as it has proved to be effective in people who are in the initial stages of the coronavirus treatment, reported news agency PTI.

The statement comes after a multicentric study by the Indian Council of Medical Research (ICMR) revealed that the use of convalescent plasma therapy in COVID-19 patients does not help in reducing deaths or preventing disease progression.

The researchers aimed to evaluate its effectiveness for coronavirus patients in the largest such randomised controlled trial, even as the therapy has been actively pushed as a treatment option in the country. On 23 August, the US Food and Drug Administration also issued an emergency use authorisation for plasma therapy as a COVID-19 treatment.

Kejriwal on Wednesday held a review meeting with Satyendar Jain, Chief Secretary Vijay Dev, senior officials, and medical superintendents of Delhi government-run hospitals and asked them to take all possible steps to prevent the spread of the virus, PTI reported.

Delhi on Wednesday reported 4,039 fresh COVID-19 cases, the highest single-day spike so far, crossing the two lakh-mark. The spike comes days after the Delhi government resumed the metro services amid high precautions.

(With inputs from PTI and Fit)

Liked this story? We'll send you more. Subscribe to The Quint's newsletter and get selected stories delivered to your inbox every day. Click to get started.

The Quint is available on Telegram & WhatsApp too, click to join.

Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!